Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses’ Vaccinated Solid Organ Transplant RecipientsArticle Published on 2022-10-192022-11-15 Journal: Viruses [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] administration analyzed booster booster dose booster doses Breakthrough infection cellular response CLIA Cohort COVID-19 dose Efficacy ELISA ELISpot assay fourth dose General population humoral IgA IgA level IgG immune immune response IMPROVE in both group Infection mRNA mRNA vaccine natural natural infection new SARS-CoV-2 no difference Organ transplant Patient positive recipient recipients repeated response SARS-CoV-2 SARS-COV-2 infection secretion serum IgG severe COVID-19 significant increase significantly increased Solid solid organ transplant Solid organ transplant recipients. Still T cell T-cell T-cell Response Transplant vaccination Vaccine vaccine-induced immune response variants of concern [DOI] 10.3390/v14102299 PMC 바로가기
Incidence of COVID-19 and Identification of Possible Risk Factors Associated with COVID-19 in Acute Renal Transplant Recipients in PakistanArticle Published on 2022-10-042022-11-15 Journal: Annals of transplantation [Category] COVID19(2023년), SARS, 진단, [키워드] acquisition age baseline Characteristics Comorbidities Compliance COVID-19 COVID-19 disease Diabetes Mellitus enrolled Factor female gender Follow-up Gender Health status hospital Hospital stay identification identify immunosuppressive therapies incidence increased mortality Infection males management measure Measures overall mortality Patient patients Protective questionnaire raised recipient recipients renal required risk factor Risk factors SARS-COV-2 infection serum creatinine susceptible symptomatic Transplant transplants with COVID-19 [DOI] 10.12659/AOT.937688 PMC 바로가기
Comparison of the immunogenicity of five COVID-19 vaccines in Sri LankaArticle Published on 2022-10-012022-11-15 Journal: Immunology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] ACE2 Alpha antibodies antibody Antibody Response AZD1222 clinical outcomes COVID-19 COVID-19 vaccine determine Effect elicited FIVE highest highlight individual lowest memory Moderna positive response RBD Receptor binding domain recipient recipients reported SARS-CoV-2 Sinopharm the antibody response the RBD total antibody vaccination vaccination. Vaccine vaccinee vaccinees variant variants of concern virus were assessed wild type [DOI] 10.1111/imm.13535 PMC 바로가기
Association Between Maintenance Immunosuppressive Regimens and COVID-19 Mortality in Kidney Transplant RecipientsArticle Published on 2022-10-012022-11-15 Journal: Transplantation [Category] 진단, [키워드] age association baseline baseline characteristics cardiovascular disease cohort study Comorbidity conducted coronavirus disease Corticosteroid COVID-19 death diabete died evaluated False positive form French high risk hypertension immune function Immunosuppression immunosuppressive immunosuppressive drug impair inhibitor kidney transplant Logistic regression lower risk maintenance mammalian men Mortality MOST multiple imputation Odds ratio outcome p value performed Rapamycin recipient recipients regimen registry retrieved risk of death serum creatinine significantly lower Solid solid organ solid organ transplant statistically significant Transplant was used with COVID-19 [DOI] 10.1097/TP.0000000000004254 PMC 바로가기
COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysisArticle Published on 2022-10-012022-11-15 Journal: Clinical and molecular hepatology [Category] 진단, [키워드] 95% CI 95% confidence interval adverse event anti-spike antibody antibody chronic hepatitis Chronic Hepatitis B chronic liver disease cirrhosis CLD collected data coronavirus disease COVID-19 COVID-19 vaccine database disease dose etiology Fatty liver groups humoral Inactivated vaccine liver liver transplant Meta-analysis mRNA vaccine neutralizing antibody Non-alcoholic fatty liver disease observational study Patient patients performed ranged recipient recipients reported SARS-CoV-2 SARS-CoV-2. seroconversion rate T cell response vaccine doses vaccine immunogenicity vaccine platform [DOI] 10.3350/cmh.2022.0087 PMC 바로가기
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathiesArticle Published on 2022-10-012022-11-15 Journal: Muscle & nerve [Category] 진단, [키워드] Active disease ADE ADEs adverse event analyzed Autoimmune benefit BNT162b2 collected comparable COVID-19 COVID-19 vaccination dermatomyositis Descriptive statistics disease dose evaluate HCs healthy control higher risk Hydroxychloroquine IBM Immunoglobulin impacted inactive Inflammatory inflammatory disorder International interquartile range investigated IQR less lower risk Major median age multivariable Myopathy myositis nine Odds ratio outcome Patient Pfizer postvaccination Rash recipients reported rheumatology risk severe COVID-19 vaccination vaccination. Vaccine was performed [DOI] 10.1002/mus.27681 PMC 바로가기
Characterization of pathogen-inactivated COVID-19 convalescent plasma and responses in transfused patientsArticle Published on 2022-10-012022-11-15 Journal: Transfusion [Category] COVID19(2023년), SARS, 진단, [키워드] 28-day mortality acute respiratory syndrome administration adverse effects adverse event adverse events antibody antibody assay Antibody Response Antibody titers Antigen assays binding case-control study CCP Characteristics characterization Control Controlled trial convalescent convalescent plasma coronavirus COVID-19 COVID-19 convalescent plasma died disease severity Donor donors enrolled evaluated group had no heterogeneous hospital Hospitalized immune response Immunosuppressed median median age Microarray NAb Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody neutralizing antibody assays neutralizing capacity not affect pathogen-reduction treatment. Patient Pneumonia recipient recipients response responses SARS CoV-2 SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV2 single-center survival symptom onset transfused transfusion treated Treatment variable with COVID-19 [DOI] 10.1111/trf.17083 PMC 바로가기
Factors Associated With COVID-19 Vaccine Response in Transplant Recipients: A Systematic Review and Meta-analysisArticle Published on 2022-10-012022-11-15 Journal: Transplantation [Category] 진단, [키워드] 95% CI 95% confidence interval age Allogeneic calcineurin Cell combating Comorbidity coronavirus disease COVID-19 COVID-19 vaccination COVID-19 vaccines dose Effects Factor General population healthy control higher risk humoral Immunocompromised Immunosuppressant immunosuppressive inclusion criteria increased risk inhibitor inhibitors mammalian medication Meta-analysis much lower Organ transplant outcome pandemic performed pooled rate Population Rapamycin receiving recipient recipients regimen response review risk factor second dose Seroconversion seroconversion failure Steroids systematic review the vaccine Transplant Vaccine vaccine response [DOI] 10.1097/TP.0000000000004256 PMC 바로가기
Differential Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Profiles After Allergic Reactions to Messenger RNA Coronavirus Disease 2019 VaccineArticle Published on 2022-09-282022-11-15 Journal: The Journal of Infectious Diseases [Category] SARS, 진단, [키워드] acute respiratory syndrome allergic allergic reaction anaphylaxis antibody antigenic target Control controls coronavirus coronavirus 2 coronavirus disease COVID-19 exhibiting full-length functional humoral Humoral immunity hypersensitivity IgG1 Immunoglobulin individual messenger Messenger RNA Moderna mounted mRNA mRNA COVID-19 vaccine occur Patient Pfizer produced profile reaction receptor recipients reduction in respiratory RNA SARS-CoV-2 significantly lower Symptom systems serology vaccination vaccination. Vaccine [DOI] 10.1093/infdis/jiac107 PMC 바로가기
Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospitalArticle Published on 2022-09-232022-11-15 Journal: Frontiers in Immunology [Category] SARS, 진단, 치료기술, [키워드] adenoviral-vectored vaccine antibodies blood sample booster Care Cell collected Covaxin COVID-19 COVID-19 case COVID-19 vaccine Covishield diminished dose elicited ELISA full-length Health care worker hospital immune response Immunity immunization immunogenicity Immunogenicity. independent India initiated IQR long-term follow up median Neutralizing Neutralizing antibody titer Observational cohort study pandemic PBMC pre-vaccination progression recipient recipients remained SARS CoV-2 Seroconversion T cell T cell response T-cell Response tested Vaccine Vaccines were recorded were used [DOI] 10.3389/fimmu.2022.928501 PMC 바로가기